Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...
An experimental drug being developed by Sanofi significantly curbed progression of aortic valve stenosis, a common heart ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Sanofi's experimental drug ataciguat has shown promise in reducing the progression of aortic valve stenosis in clinical trials, potentially delaying the need for surgical valve replacement. With ...
Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally. Researchers are exploring the use of a new drug called ataciguat to manage ...
News Medical on MSN1d
New drug ataciguat shows promise for managing aortic valve stenosisAortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.
Sue Dumbauld got an alert from her Apple Watch that her heart rate was dangerously high. This inspired her to exercise ahead ...
Women are often underdiagnosed and undertreated when it comes to heart disease, particularly conditions like aortic stenosis.
Discover how recent advancements in cardiovascular medicine, including TAVI and TEER, are revolutionizing heart disease ...
While the Apple Watch alarm went off, Sue was on a call and thought that the noise she was hearing was an Amber Alert. When ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback